X4 Pharmaceuticals alla Leerink Global Healthcare Conference: Svolta Strategica verso l’Ematologia Rara
X4 Pharmaceuticals, Inc. (XFOR) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript